The DNA encoding VSTx1 was inserted into the pET-30 Xa/LIC plasmid (Novagen) with a Factor Xa cleavage site between an N-terminal hexahistidine tag and VSTx1 sequences. VSTx1 was expressed in
E. coli BL21 (DE3) cells. The uniformly
15N- and
13C,
15N-labeled samples were prepared by growing the transformants in M9 minimal medium containing
15NH
4Cl, glucose or [
13C] glucose and [
15N] or [
13C,
15N] Celtone® base powder, respectively. Similarly, the uniformly
2H,
15N-labeled samples were prepared by growing the transformants in M9 minimal medium containing 99%
2H
2O,
15NH
4Cl, [
2H] glucose and [
2H,
15N] Celtone® base powder. The cells were grown at 37 °C to an A
600 of 0.6 to 0.8 and protein expression was induced with 1.0 mM isopropyl ß-D-1-thiogalactopyranoside (IPTG) for 6 h at 37 °C. The cells were harvested and lysed by sonication, followed by centrifugation. The pellets were solubilized by 8.0 M urea. VSTx1 was purified from the supernatant of the centrifuged lysate by a
HIS-Select® Nickel Affinity Gel (Sigma) column. The eluted VSTx1 was refolded by dialysis, followed by digestion with Factor Xa protease (Novagen). The cleaved hexahistidine tags were removed by
HIS-Select® Nickel Affinity Gel column. VSTx1 was further purified by the reverse phase high performance liquid chromatography using an
ODS-AM column (YMC).
Ozawa S.I., Kimura T., Nozaki T., Harada H., Shimada I, & Osawa M. (2015). Structural basis for the inhibition of voltage-dependent K+ channel by gating modifier toxin. Scientific Reports, 5, 14226.